These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15365044)

  • 1. Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp.
    Castro C; Serrano MC; Flores B; Espinel-Ingroff A; Martín-Mazuelos E
    J Clin Microbiol; 2004 Sep; 42(9):4358-60. PubMed ID: 15365044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J; Peláez T; Alcalá L; Bouza E
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC; Hsieh MI; Choi PC; Wu CJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
    Chryssanthou E; Cuenca-Estrella M
    Clin Microbiol Infect; 2006 Sep; 12(9):901-4. PubMed ID: 16882296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole.
    Serrano MC; Morilla D; Valverde A; Chávez M; Espinel-Ingroff A; Claro R; Ramírez M; Mazuelos EM
    J Clin Microbiol; 2003 Nov; 41(11):5270-2. PubMed ID: 14605181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp.
    Serrano MC; Ramírez M; Morilla D; Valverde A; Chávez M; Espinel-Ingroff A; Claro R; Fernández A; Almeida C; Martín-Mazuelos E
    J Antimicrob Chemother; 2004 May; 53(5):739-42. PubMed ID: 15056643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD; Kiraz N
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Sensititre YeastOne colorimetric antifungal panel with the modified Clinical and Laboratory Standards Institute broth microdilution (M38-A) method for antifungal susceptibility testing of dermatophytes.
    Castro C; Serrano MC; Valverde A; Pemán J; Almeida C; Martín-Mazuelos E
    Chemotherapy; 2008; 54(6):427-30. PubMed ID: 18824849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of voriconazole against Prototheca wickerhamii: comparative evaluation of sensititre and NCCLS M27-A2 methods of detection.
    Linares MJ; Solís F; Casal M
    J Clin Microbiol; 2005 May; 43(5):2520-2. PubMed ID: 15872301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole.
    Yamaguchi H; Uchida K; Nagino K; Matsunaga T
    J Infect Chemother; 2002 Dec; 8(4):374-7. PubMed ID: 12525904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
    Pai MP; Jones AL
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4441-3. PubMed ID: 15504877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.
    Espinel-Ingroff A; Rezusta A
    J Clin Microbiol; 2002 Jun; 40(6):2101-7. PubMed ID: 12037072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp.
    Maesaki S; Iwakawa J; Higashiyama Y; Miyazaki Y; Yanagihara K; Tomono K; Tashiro T; Kohno S
    J Infect Chemother; 2000 Jun; 6(2):101-3. PubMed ID: 11810544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole.
    Berthet N; Faure O; Bakri A; Ambroise-Thomas P; Grillot R; Brugère JF
    J Antimicrob Chemother; 2003 Jun; 51(6):1419-22. PubMed ID: 12716778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay.
    Balajee SA; Imhof A; Gribskov JL; Marr KA
    J Antimicrob Chemother; 2005 Jan; 55(1):102-5. PubMed ID: 15546970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.
    Pfaller MA; Espinel-Ingroff A; Jones RN
    J Clin Microbiol; 2004 Oct; 42(10):4577-80. PubMed ID: 15472311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
    Lewis RE; Kontoyiannis DP
    J Antimicrob Chemother; 2005 Nov; 56(5):887-92. PubMed ID: 16188916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of the Sensititre YeastOne plate for testing susceptibility of filamentous fungi to posaconazole.
    Patel R; Mendrick C; Knapp CC; Grist R; McNicholas PM
    J Clin Microbiol; 2007 Jun; 45(6):2000-1. PubMed ID: 17428931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.